Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 3.


Sharman, Jeff P, Coutre, Steven E, Furman, Richard R, Cheson, Bruce D, Pagel, John M, Hillmen, Peter, Barrientos, Jacqueline C, Zelenetz, Andrew D, Kipps, Thomas J, Flinn, Ian W
et al (show 14 more authors) (2019) Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia. Journal of Clinical Oncology, 37 (16). 1391 - 1402.


Ghia, Paolo, Coutre, Steven E, Cheson, Bruce D, Barrientos, Jacqueline C, Hillmen, Peter, Pettitt, Andrew R, Zelenetz, Andrew D, Shreay, Sanatan, Hallek, Michael and Furman, Richard R
(2020) Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial. HAEMATOLOGICA, 105 (10). E519 - E522.


Kreuzer, Karl-Anton, Furman, Richard R, Stilgenbauer, Stephan, Dubowy, Ronald L, Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara
et al (show 4 more authors) (2020) The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab. Leukemia, 34 (1). 296 - 300.

This list was generated on Mon Aug 30 05:17:57 2021 BST.